Key terms

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest SLS news

Apr 11 8:46am ET Largest borrow rate increases among liquid names by TipRanks Apr 02 10:30am ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Mar 28 4:54pm ET Sellas Life Sciences files to sell 13.03M shares of common stock for holders by TipRanks Mar 28 4:49pm ET Sellas Life Sciences files $200M mixed securities shelf by TipRanks Mar 28 4:12pm ET Sellas Life Sciences reports 2023 EPS ($1.34), consensus ($1.08) by TipRanks Mar 28 7:06am ET Sellas Life Sciences-licensed GFH009 included in trial combination for lymphoma by TipRanks Mar 27 2:25pm ET Buy Rating for SELLAS Life Sciences Amid Positive AML Study Results and Strengthened Financials by TipRanks Mar 27 8:46am ET Largest borrow rate increases among liquid names by TipRanks Mar 22 8:46am ET Largest borrow rate increases among liquid names by TipRanks Mar 21 2:50pm ET Sellas Life Sciences options imply 20.1% move in share price post-earnings by TipRanks Mar 15 9:08am ET Sellas prices 13.03M shares at $1.535 in direct offering, private placement by TipRanks Mar 14 2:34pm ET Sellas Life Sciences options imply 12.0% move in share price post-earnings by TipRanks Mar 08 4:23pm ET SELLAS Life Sciences Announces Executive Shake-up and Reorganization Strategy by TipRanks Mar 08 8:11am ET Sellas Life announces departure of CCO Francomano, General Counsel Wood by TipRanks Mar 07 8:45am ET Largest borrow rate increases among liquid names by TipRanks Mar 06 8:45am ET Largest borrow rate increases among liquid names by TipRanks Mar 04 8:45am ET Largest borrow rate increases among liquid names by TipRanks Mar 01 8:35am ET Sellas Life Sciences delivers oral presentation of SLS009 Phase 1 data by TipRanks Feb 29 8:27am ET Sellas Life Sciences to present SLS009 Phase 1 data ay 2024 ESH by TipRanks Feb 26 8:45am ET Largest borrow rate increases among liquid names by TipRanks Feb 16 4:28pm ET SELLAS Life Sciences Faces Nasdaq Minimum Bid Price Warning by TipRanks Feb 08 7:07am ET Sellas price target lowered to $7.50 from $8 at Alliance Global Partners by TipRanks Feb 06 8:32am ET Sellas Life Sciences announces publication of preclinical data on SLS009 by TipRanks

No recent news articles are available for SLS

No recent press releases are available for SLS

SLS Financials

1-year income & revenue

Key terms

SLS Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

SLS Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel
JPMorgan beat earnings expectations this Friday, unofficially kicking off the first quarter earnings season.
Win McNamee/Getty Images
Jamie Dimon says chance of a bad economy is ‘higher than other people think’